Skip to content
Clinical Trials – home
Research site

Izerskie Centrum Pulmonologii I Chemioterapii Izer-Med Sp. z o.o.

Poland Ul. Sanatoryjna 1, 58-580 Szklarska Poreba, Poland

  • Small cell lung cancer extensive stage · Non-small cell lung cancer metastatic
  • Adult patients

About Specializations

Izerskie Centrum Pulmonologii I Chemioterapii Izer-Med Sp. z o.o. in Szklarska Poreba, Poland specialises in clinical trials of conditions such as Small cell lung cancer extensive stage, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology and Respiratory Diseases

At Izerskie Centrum Pulmonologii I Chemioterapii Izer-Med Sp. z o.o. in Szklarska Poreba, clinical research is focused on cancer and lung disease, with studies centered on advanced small cell lung cancer and non-small cell lung cancer. These trials are designed to assess whether new treatment approaches can improve survival and disease control for patients with hard-to-treat respiratory cancers.

  • Research in extensive stage small cell lung cancer is evaluating whether a supportive treatment strategy can help maintain outcomes when given alongside chemotherapy.
  • Studies in metastatic non-small cell lung cancer are comparing a new immunotherapy-based approach with an established treatment option to see which better improves patient outcomes.

The site’s work combines oncology and pulmonology, reflecting a strong interest in therapies for cancers that affect the lungs and surrounding respiratory system.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Sanatoryjna 158-580 Szklarska PorebaPoland
Recruiting now
no trials
Conditions studied
2

More sites in Szklarska PorebaPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Pharmacosmos A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.